Drug compositions include (1R, 4R) - 6 - Phi 1R, 4R - 6 9, 4 N-deldeldelta delta deldeldeldelta _and_mu pi_pi pi___-4-

摘要

The invention concerns a pharmaceutical formulation containing a first pharmacologically active ingredient selected from (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1, 1'-pyrane[3,4,b]indiuml]-4-amine and its normally accepted salts and a second pharmacologically active ingredient, which is a non-steroidal anti-waste drug selected by the group consists of indomethacindichilfenac,Sulydaki,tolmetine,zombie,aclophenac,bumadisone,Etdolakis,Ionazolaki,fediazac,acemetacin,diphenpyramide,oxamethacin,proglumetacin,cetorolac,acelephenac,buffexamax,mefenamic acid,tolfenamic acid,flufenamic acid,meclofenamic acid and its normally acceptable salts.